Survival and prognostic factors of death risk in antiphospholipid syndrome: results of 8-year follow-up

Survival and prognostic factors of death risk in antiphospholipid syndrome: results of 8-year follow-up

Aim. To evaluate survival and mortality in antiphospholipid syndrome (APS) as well as prognostic factors of APS deterioration. Material and methods. We retrospectively studied 248 case histories of patients admitted to the Institute of Rheumatology for 8 years. Primary APS was diagnosed in 35 patien...

Bibliografske podrobnosti
Main Authors:	T M Reshetnyak, Z S Alekberova, G P Kotelnikova, E N Alexandrova, E S Mack, S G Radenska-Lopovok, L A Kalashnikova, V A Nasonova
Format:	Article
Jezik:	Russian
Izdano:	"Consilium Medicum" Publishing house 2003-05-01
Serija:	Терапевтический архив
Teme:	antiphospholipid syndrome primary and secondary survival prognostic factors systemic lupus erythematosus
Online dostop:	https://ter-arkhiv.ru/0040-3660/article/view/29375

Podobne knjige/članki

Anticardiolipine antibodies in skin and muscle eluates of patients with primary and secondary antiphospholipid syndrome
od: Z S Alekberova, et al.
Izdano: (2004-08-01)

Clinical and endoscopic assessment of gastric state in systemic lupus erythematosus and antiphospholipid syndrome
od: I. A. Doroshkevich, et al.
Izdano: (2004-06-01)

ANTIPHOSPHOLIPID SYNDROME: DIAGNOSIS AND CLINICAL MANIFESTATIONS (A LECTURE)
od: Tat’yana M Reshetnyak
Izdano: (2014-03-01)

Blood nitrates content in patients with systemic lupus erythematosus and antiphospholipid syndrome
od: D V Reshetnyak, et al.
Izdano: (2004-05-01)

ANTIPHOSPHOLIPID SYNDROME AND SYSTEMIC LUPUS ERYTHEMATOSUS: WHAT DISEASE IS A CAUSE OF ORGAN DAMAGES?
od: F. A. Cheldieva, et al.
Izdano: (2020-04-01)

Antiphospholipid syndrome and exogenic factors ofthromboses risk
od: E S Mach, et al.
Izdano: (2004-11-01)

Von Willebrand factor antigen in systemic lupus erythematosus and antiphospholipid syndrome
od: A A Novikov, et al.
Izdano: (2004-08-01)

C-reactive protein in antiphospholipid syndrome: relationship with cardiovascular pathology
od: N V Seredavkina, et al.
Izdano: (2009-08-01)

Pediatric antiphospholipid syndrome
od: Petrović Gordana, et al.
Izdano: (2023-01-01)

Antibodies to the phosphatidylserine/prothrombin complex in the diagnosis of antiphospholipid syndrome
od: Tatiana M. Reshetnyak, et al.
Izdano: (2022-06-01)

Clinical and immunological features of primary and secondary antiphospholipid syndrome
od: T M Reshetnvak, et al.
Izdano: (2004-08-01)

Echocardiographic Abnormalities and Antiphospholipid Antibodies in Patients with Systemic Lupus Erythematosus
od: Creso Abreu Falcão, et al.
Izdano: (2002-09-01)

The role of clinically significant antiphospholipid antibodies in systemic lupus erythematosus
od: M. Taraborelli, et al.
Izdano: (2016-12-01)

Primary antiphospholipid syndrome progressing to systemic lupus erythematosus: a case report
od: Rocco Manganelli, et al.
Izdano: (2013-04-01)

SECONDARY ANTIPHOSPHOLIPID SYNDROME REVEALED BY THE SUDDEN ONSET OF PNEUMONIA-CASE REPORT
od: Lazovic Biljana, et al.
Izdano: (2019-12-01)

Hyperhomocysteinemia - an additional risk factor of thrombosis in systemic lupus erythematosus and antiphospholipid syndrome
od: I. E. Shirokova, et al.
Izdano: (2003-08-01)

STUDIES DEVOTED TO ANTIPHOSPHOLIPID SYNDROME AT THE V.A. NASONOVA RESEARCH INSTITUTE OF RHEUMATOLOGY: MAIN ACHIEVEMENTS (ON THE OCCASION OF THE 40th ANNIVERSARY OF THE DISSERTATION BOARD)
od: T. M. Reshetnyak
Izdano: (2017-01-01)

Global antiphospholipid syndrome score (GAPSS) in patients with systemic lupus erythematosus
od: F. A. Cheldieva, et al.
Izdano: (2022-11-01)

An Antiphospholipid Antibody Profile as a Biomarker for Thrombophilia in Systemic Lupus Erythematosus
od: Ryo Hisada, et al.
Izdano: (2023-03-01)

Type I interferon pathway activation across the antiphospholipid syndrome spectrum: associations with disease subsets and systemic antiphospholipid syndrome presentation
od: Irene Cecchi, et al.
Izdano: (2024-03-01)

Vaccination of pneumococcal infection in patients with systemic lupus erythe matosus and antiphospholipid syndrome: experience of 6 years of use
od: G. M. Tarasova, et al.
Izdano: (2023-06-01)

Thrombotic microangiopathy in rheumatology: a link between thrombosis and autoimmunity
od: Evgeny L. Nasonov, et al.
Izdano: (2020-06-01)

Digital ulcers as presenting symptom of secondary antiphospholipid syndrome
od: Karen Cravero, PhD, et al.
Izdano: (2022-11-01)

Origin and pathogenesis of antiphospholipid antibodies
od: C.M. Celli, et al.
Izdano: (1998-06-01)

Netosis in the pathogenesis of antiphospholipid syndrome and systemic lupus erythematosus
od: K. S. Nurbaeva, et al.
Izdano: (2021-10-01)

RECURRENT FETAL LOSS IN THE PRIMARY ANTIPHOSPHOLIPID SYNDROME (CASE REPORT)
od: Z S Alekberova, et al.
Izdano: (2000-02-01)

Secondary antiphospholipid syndrome in systemic lupus erythematosus – screening, diagnosis and treatment methods
od: Andrei-Bogdan Mihailescu, et al.
Izdano: (2022-06-01)

Extensive abdominal wall ulceration as a late manifestation of antiphospholipid syndrome: a case report
od: Yogesh Sharma, et al.
Izdano: (2018-08-01)

Anesthetic management of patient with systemic lupus erythematosus and antiphospholipid antibodies syndrome for laparoscopic nephrectomy and cholecystectomy
od: Rashid Saeed Khokhar, et al.
Izdano: (2015-01-01)

Acute Systemic Lupus Erythematous and Antiphospholipid Syndrome With Cardiac Complications
od: Manish Motwani, MBChB, PhD, et al.
Izdano: (2019-08-01)

Contraception for antiphospholipid syndrome and systemic lupus erythematosus (according to the recommendations of the European Alliance of Associations for Rheumatology/American College of Rheumatology, EULAR/ACR)
od: T. M. Reshetnyak, et al.
Izdano: (2024-03-01)

Difficulties in management of patients with systemic lupus erythematosus and antiphospholipid syndrome in combination with melanoma and infiltrative tuberculosis (clinical observations)
od: A. A. Shumilova, et al.
Izdano: (2021-08-01)

Splenic infarcts in a lady with systemic lupus erythematosus and negative antiphospholipid antibodies—A rare case report
od: Amr Ashour, et al.
Izdano: (2023-03-01)

Renal Involvement in Antiphospholipid Syndrome
od: Alonso Turrent-Carriles, et al.
Izdano: (2018-05-01)

Long-Term Anticoagulation Therapy for Antiphospholipid Syndrome Following Unsuccessful Arterial Thrombosis Stent Procedure: A Case Report
od: Hyun Sik Kang
Izdano: (2023-04-01)

Arterial/venous thrombosis, fetal loss and stillbirth in pregnant women with systemic lupus erythematosus versus primary and secondary antiphospholipid syndrome: a systematic review and meta-analysis
od: Pravesh Kumar Bundhun, et al.
Izdano: (2018-06-01)

Predictors and clinical complications associated with antiphospholipid antibodies in sickle cell disease
od: Claudia Rodriguez Rivera, et al.
Izdano: (2023-02-01)

Libman-Sacks endocarditis in patients with systemic lupus erythematosus with secondary antiphospholipid syndrome
od: Yousef Mohammadi Kebar, et al.
Izdano: (2019-06-01)

Four clinical and biological phenotypes in antiphospholipid syndrome: a cluster analysis of 174 patients with antinuclear antibody tests
od: Marie Ottavi, et al.
Izdano: (2024-02-01)

Case Report: A case of recurrent thrombosis in pediatric antiphospholipid syndrome associated with pediatric onset systemic lupus
od: Lingjuan Liu, et al.
Izdano: (2023-02-01)